Gilles C. Pelisson - 15 May 2024 Form 4 Insider Report for Accenture plc (ACN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 May 2024, 09:08:03 UTC
Prior SEC filing
14 May 2024
Next SEC filing
16 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Danika Haueisen, Attorney-In-Fact for Gilles C. Pelisson

Key filing fact

Gilles C. Pelisson filed Form 4 for Accenture plc (ACN) on 17 May 2024.

Key facts

  • This page summarizes Gilles C. Pelisson's Form 4 filing for Accenture plc (ACN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 May 2024, 09:08.

Change

  • Previous filing in this sequence was filed on 14 May 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACN transaction

Class A ordinary shares

Award

Transaction value
$0
Shares
+5
Change %
+0.11%
Price
$0.000000
Shares after
4,483
Date
15 May 2024
Ownership
Direct
Footnotes
F1
ACN holding

Class A ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,951
Date
15 May 2024
Ownership
See footnote
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Footnote F2

Class A Ordinary Shares are held by a holding entity over which Mr. Pelisson has investment control. Mr. Pelisson disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .